Last reviewed · How we verify
Diphtheria-Tetanus Toxoids Adsorbed
Diphtheria-Tetanus Toxoids Adsorbed, marketed by Grifols Therapeutics LLC, is a well-established vaccine in the preventive immunization market. A key strength is the protection it offers against diphtheria and tetanus, leveraging a proven mechanism of action. The primary risk is the key composition patent expiry in 2028, which could lead to increased competition from generic alternatives.
At a glance
| Generic name | Diphtheria-Tetanus Toxoids Adsorbed |
|---|---|
| Sponsor | Grifols Therapeutics LLC |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial (PHASE4)
- A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) (PHASE1)
- Immunosuppression and COVID-19 Boosters (PHASE3)
- Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine (PHASE1, PHASE2)
- A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in Infants (PHASE2)
- Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (PHASE2)
- Confirmatory Study of BK1310 in Healthy Infants (PHASE3)
- Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diphtheria-Tetanus Toxoids Adsorbed CI brief — competitive landscape report
- Diphtheria-Tetanus Toxoids Adsorbed updates RSS · CI watch RSS
- Grifols Therapeutics LLC portfolio CI